Status:
COMPLETED
Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Dexmedetomidine Induced Sedation
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The investigators are doing this research study to find out how and where dexmedetomidine, a sedative anesthetic, acts in the brain. The investigators will do this by using a machine that records the ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I
- 18 to 35 years of age
Exclusion
- MRI and/or PET screening criteria not met
- Abnormal sleep habits/known or suspected sleep disorder(s)
- Taking medication that alters sleep, cognitive function, or both -History of a known neurological or psychiatric problem -Younger than 18 or older than 35 years of age
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01485380
Start Date
September 1 2012
End Date
July 1 2013
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114